UF researcher receives grant for clinical trial for malignant pediatric gliomas
The grant will fund a phase I/II clinical trial for malignant pediatric gliomas using 8R-70CAR T cells.
The grant will fund a phase I/II clinical trial for malignant pediatric gliomas using 8R-70CAR T cells.
Jiang Bian, Ph.D., director of the Cancer Informatics Shared Resource at the Cancer Center, is making UF Health’s IT infrastructure “AI ready.”
The study will focus on understanding the role of DAXX in triple negative breast cancer.
The UF Health Cancer Center's Research Day 2023 on Jan. 11 drew a record number of submissions as the event returned to an in-person format.
The study aims to define the impact of the proteomic and metabolomic landscape of leukemic cells on patient risk and therapeutic outcome.
The UF Health Cancer Center will be presenting at the 2023 ASCO Gastrointestinal Cancers Symposium.
Elias Sayour, M.D., Ph.D., co-leader of the Cancer Center's CTHR research program, discussed the potential of mRNA cancer vaccines in The Daily Beast.
The new research will focus on making a tumor model to test new immunotherapies.
Two UF College of Pharmacy graduate students were honored with abstract awards at the 2022 ASH Annual Meeting in New Orleans.
ESPN and ABC aired videos highlighting UF Health’s efforts to fight brain cancer.